Next, to determine whether phosphorylation of the p38 MAPK pathway may contribute to the activation of COX-2/PGE2 and depression in rats, we injected SB203580 to block p38 MAPK activity prior to CUMS exposure. This evidence concerns the gene PTGS2 and depressive disorder.